1358 logo

PW Medtech Group Limited Stock Price

SEHK:1358 Community·HK$2.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

1358 Share Price Performance

HK$1.33
0.31 (30.39%)
HK$1.33
0.31 (30.39%)
Price HK$1.33

1358 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and good value.

2 Risks
1 Reward

PW Medtech Group Limited Key Details

CN¥844.9m

Revenue

CN¥400.3m

Cost of Revenue

CN¥444.6m

Gross Profit

CN¥298.0m

Other Expenses

CN¥146.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.10
52.62%
17.35%
0.3%
View Full Analysis

About 1358

Founded
1997
Employees
1356
CEO
Yue'e Zhang
WebsiteView website
www.pwmedtech.com

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices; high flux hemodialyzers, low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines; and animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People’s Republic of China.

Recent 1358 News & Updates

Recent updates

No updates